Description/Summary
Supplementary figure for the forthcoming publication entitled “Overlapping roles of NADPH Oxidase 4 (Nox4) for diabetic and gadolinium-based contrast agent-induced systemic fibrosis”. Supplementary Figure 2 demonstrates renal changes induced by gadolinium-based contrast agent treatment and experimental diabetes. Photomicrographs analyzed by a blinded veterinary pathologist.
Publication Date
2021
Document Type
Article
File Format
Recommended Citation
Bruno, Francesca; Joshua DeAguero; Catherine Do; Doug Yoon Lee; Chunyan Tan; G Patricia Escobar; and Brent Wagner. "Overlapping roles of NADPH Oxidase 4 (Nox4) for diabetic and gadolinium-based contrast agent-induced systemic fibrosis-Animal Equivalent Dosing of Gadolinium-based contrast agents Supplementary Figure 2." (2021). https://digitalrepository.unm.edu/kinm/3
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis
Comments
The article associated with this dataset is "Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis" attached at the bottom of the file list.
Bruno F, DeAguero J, Do C, Lee DY, Tan C, Escobar GP, Wagner B. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis. Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F617-F627. doi: 10.1152/ajprenal.00456.2020. Epub 2021 Feb 22. PMID: 33615889; PMCID: PMC8083972.